Boulder Peptide Symposium 2026
Date: September 28 – October 1, 2026
Location: Napa, California
Event Webpage: https://boulderpeptide.org/overview/
JOIN US!
Learn how Catalent is advancing oral drug development and delivery of macromolecules with modified release technology, bioavailability enhancement and scientific innovation. Meet with our experts to see how we can support your next breakthrough to bring better treatment to market and to patients.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS!
Speaker: Karunakar (Karu) Sukuru, R.Ph., Ph.D., Global Vice President, Pharma Product Development & Head of Scientific Advisory
Date/Time: Tuesday, September 29, 2026 at 2:45pm
Title: Unlocking Oral Delivery for Peptides Leveraging Lipid-Based Formulations
Peptides face significant obstacles when administered orally, including exposure to acidic conditions, enzymatic digestion and poor membrane transport. To address these issues, advanced technologies such as lipid-based carriers and enteric softgel systems are being leveraged. These solutions aim to protect molecules, optimize site-specific release, and improve absorption through alternative pathways like the lymphatic system. This talk will highlight the scientific foundation and recent data supporting these approaches, as well as current trends shaping the field.
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
